Bloomberg Anywhere Login

Bloomberg

Connecting decision makers to a dynamic network of information, people and ideas, Bloomberg quickly and accurately delivers business and financial information, news and insight around the world.

Company

Financial Products

Enterprise Products

Media

Customer Support

  • Americas

    +1 212 318 2000

  • Europe, Middle East, & Africa

    +44 20 7330 7500

  • Asia Pacific

    +65 6212 1000

Communications

Industry Products

Media Services

Follow Us


Last $2.26 USD
Change Today +0.06 / 2.73%
Volume 691.9K
AMRN On Other Exchanges
Symbol
Exchange
NASDAQ GM
Frankfurt
As of 8:10 PM 07/31/15 All times are local (Market data is delayed by at least 15 minutes).

Executive Profile*

Paul E. Huff

Chief Commercial Officer and Senior Vice President, Amarin Corporation plc
AgeTotal Calculated CompensationThis person is connected to 9 board members in 1 different organizations across 2 different industries.

See Board Relationships
56--

Background*

Mr. Paul E. Huff has been Chief Commercial Officer of Amarin Corporation plc since 2010 and serves as its Senior Vice President. Mr. Huff served as Vice President of Business Development and Vice President of Marketing at Reliant Pharmaceuticals, Inc. and played a pivotal role in the launch and successful commercialization of Lovaza. He joined Reliant in February 2004 and has over 25 years of experience in the pharmaceutical industry, primarily in cardiovascular marketing. ...

Read Full Background

Corporate Headquarters*

2 Pembroke House
Dublin, Co. Dublin 2

Ireland

Phone: 353 1 669 9020
Fax: --

Board Members Memberships*

Director

Education*

BS
University of Maryland

Other Affiliations*

Annual Compensation*

There is no Annual Compensation data available.

Stock Options*

There is no Stock Options data available.

Total Compensation*

There is no Total Compensation data available.
*Data is at least as current as the most recent Definitive Proxy.
 

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup
Recently Viewed
AMRN:US $2.26 USD +0.06

COMPETITOR COMPENSATION

NamePosition/
Company
Compensation
Richard F. Pops Chairman of the Board and Chief Executive Officer
Alkermes plc
$854.7K
Herve Hoppenot Chief Executive Officer, President, Director and Member of Non-Management Stock Option Committee
Incyte Corporation
$2.9M
Ariel Katz Chief Executive Officer and President
Enzymotec Ltd.
$301.0K
Craig A. Wheeler Chief Executive Officer, President and Executive Director
Momenta Pharmaceuticals Inc.
$643.4K
Bruce C. Cozadd Co-Founder, Executive Chairman and Chief Executive Officer
Jazz Pharmaceuticals Public Limited Company
$830.0K
Compensation as of Fiscal Year 2014.

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact AMARIN CORP PLC -ADR, please visit . Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.